Literature DB >> 8651130

Serial measures of plasma homocyst(e)ine after acute myocardial infarction.

W Egerton1, J Silberberg, R Crooks, C Ray, L Xie, N Dudman.   

Abstract

To determine whether plasma levels of homocyst(e)ine are affected by the acute phase response, we studied 10 subjects serially after acute myocardial infarction. Our data indicate that measurement of homocyst(e)ine in patients with myocardial infarction should ideally be deferred for 7 days if spuriously low levels are to be averted.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8651130     DOI： 10.1016/s0002-9149(97)89213-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Blood levels of homocysteine and atherosclerotic vascular disease.

Authors:  W G Christen; P M Ridker
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up.

Authors:  U B Fallon; Y Ben-Shlomo; P Elwood; J B Ubbink; G D Smith
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

4.  Serum total homocysteine and coronary heart disease: prospective study in middle aged men.

Authors:  P H Whincup; H Refsum; I J Perry; R Morris; M Walker; L Lennon; A Thomson; P M Ueland; S B Ebrahim
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

5.  Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.

Authors:  Maria Rosa Biagini; Alessandro Tozzi; Rossella Marcucci; Rita Paniccia; Sandra Fedi; Stefano Milani; Andrea Galli; Elisabetta Ceni; Marco Capanni; Raffaele Manta; Rosanna Abbate; Calogero Surrenti
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

6.  Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes.

Authors:  M K Al-Obaidi; P J Stubbs; R Amersey; M I Noble
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

7.  Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.

Authors:  G L Booth; E E Wang
Journal:  CMAJ       Date:  2000-07-11       Impact factor: 8.262

Review 8.  The association of homocysteine and coronary artery disease.

Authors:  Gregory M Gauthier; Jon G Keevil; Patrick E McBride
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

9.  Comparison of Novel Coronary Artery Disease Risk Factors between Obese and Normal Adolescent.

Authors:  Samaneh Kouzehgaran; Rahim Vakili; Mohsen Nematy; Mohamad Safarian; Majid Ghayour-Mobarhan; Mohamad Khajedaluee
Journal:  Iran J Med Sci       Date:  2015-07

10.  Metabolomic strategy for studying the intervention and the synergistic effects of the shexiang baoxin pill for treating myocardial infarction in rats.

Authors:  Li Xiang; Peng Jiang; Shuping Wang; Yaohua Hu; Xiaojun Liu; Rongcai Yue; Weidong Zhang; Runhui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.